Severe digital ischemia due to systemic sclerosis successfully treated with bosentan: case report Tratamento de isquemia digital severa em paciente com esclerose sistêmica utilizando bosentana: relato de caso

Severe digital ischemia due to systemic sclerosis successfully treated with bosentan: case report Tratamento de isquemia digital severa em paciente com esclerose sistêmica utilizando bosentana: relato de caso

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by cutaneous and visceral fibrosis and widespread vascular pathology. Raynaud's phenomenon is one of the most common manifestations of SSc. It may lead to complications such as digital ulceration and infarction an...

Full description

Bibliographic Details
Main Authors:	Cesar José Guimarães Soares, Boris A. Cruz
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2007-09-01
Series:	Jornal Vascular Brasileiro
Subjects:	Esclerose sistêmica isquemia digital bosentan Systemic sclerosis digital ischemia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492007000300011

Similar Items

Bosentana no tratamento de úlceras de extremidades refratárias na esclerose sistêmica Bosentan in the treatment of refractory extremities ulcers in systemic sclerosis
by: Henrique de Ataíde Mariz, et al.
Published: (2009-06-01)

Protective Effect Of Bosentan In Experimental Cerebral Ischemia-Reperfusion Injury
by: Eser Ataş, et al.
Published: (2013-02-01)

Use of Bosentan, Theophylline and Vardenafil in Treatment of Priapism
by: Ihsan Unus, et al.
Published: (2016-03-01)

Electrophysiological Effects of Bosentan in Rats with Induced Cerebral Ischemia-Reperfusion
by: Bekir Akgun, et al.
Published: (2013-08-01)

Effect of bosentan therapy in persistent pulmonary hypertension of the newborn
by: Gunlawadee Maneenil, et al.
Published: (2018-02-01)

Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers
by: E. Catarsi, et al.
Published: (2013-05-01)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
by: Pierangelo Chinello, et al.
Published: (2011-11-01)

Role of endothelin-1 antagonist; bosentan, against cisplatin-induced nephrotoxicity in male and female rats
by: Zahra Jokar, et al.
Published: (2015-01-01)

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
by: S N Avdeev
Published: (2015-09-01)

D-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension
by: Elham Ghasemian, et al.
Published: (2016-06-01)

Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
by: Z S Valieva, et al.
Published: (2017-08-01)

Current status of bosentan for treatment of pulmonary hypertension
by: Raja Shahzad, et al.
Published: (2008-01-01)

First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
by: S N Avdeev, et al.
Published: (2013-03-01)

Bosentan, a drug used in the treatment of pulmonary hypertension, can prevent development of osteoporosis
by: Duygu Köse, et al.
Published: (2021-07-01)

Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far
by: José Antonio Morales-Molina, et al.
Published: (2011-10-01)

Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
by: Yuchen Wang, et al.
Published: (2019-07-01)

A new hope in the treatment of coronary vasospasm: bosentan
by: İlker Gül, et al.
Published: (2013-10-01)

Use of Bosentan in neonatal post cardiac surgery pulmonary hypertension
by: Pawar Ravindra, et al.
Published: (2009-01-01)

Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis
by: Naomi Onda, et al.
Published: (2015-01-01)

Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes
by: Patricia Bogdanov, et al.
Published: (2018-11-01)

Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
by: A V Volkov, et al.
Published: (2014-05-01)

A successful cesarean delivery without fetal or maternal morbidity in an Eisenmenger patient with cor triatriatum sinistrum, double-orifice mitral valve, large ventricular septal defect, and single ventricle who was under long-term bosentan treatment
by: Hacer Ceren Tokgöz, et al.
Published: (2017-03-01)

Lower doses of bosentan in combination with sildenafil might be beneficial in pulmonary arterial hypertension
by: Ahmad Amin, et al.
Published: (2015-01-01)

Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis
by: A V Volkov, et al.
Published: (2015-01-01)

Läkemedelsbehandling vid CTEPH : Behandling med bosentan och sildenafil vid pulmonell hypertension vid kronisk lungemboli
by: Elander, Astrid
Published: (2017)

Preventive role of endothelin antagonist on kidney ischemia: Reperfusion injury in male and female rats
by: Nazgol Esmalian Afyouni, et al.
Published: (2015-01-01)

Bosentan en hipertensión arterial pulmonar: Análisis del costo y comportamiento de la dispensación desde el inicio de su comercialización en Colombia
by: Oswaldo Sanchez-Villalobos, et al.
Published: (2018-06-01)

Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
by: O A Arkhipova, et al.
Published: (2018-06-01)

Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
by: Arkhipova O.A., et al.
Published: (2018-05-01)

Esclerose sistêmica e sarcoidose Scleroderma and sarcoidosis
by: Fernanda Guidolin, et al.
Published: (2005-10-01)

Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension
by: T V Martyniuk, et al.
Published: (2013-01-01)

Envolvimento Gastrointestinal na Esclerose Sistémica
by: André Real, et al.
Published: (2018-03-01)

Alterações retrococleares na esclerose sistêmica
by: Valente, Júlia de Souza Pinto
Published: (2017)

Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids
by: S. Parisi, et al.
Published: (2014-03-01)

Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension
by: Shutan Liao, et al.
Published: (2019-08-01)

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial
by: Carmine Dario Vizza, et al.
Published: (2017-09-01)

Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
by: N A Tsareva
Published: (2013-12-01)

Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption
by: Lydia A. Hanna, et al.
Published: (2017-01-01)

Sildenafil and bosentan plasma concentrations in a human immunodeficiency virus-infected patient with pulmonary arterial hypertension treated with ritonavir-boosted protease inhibitor
by: Pierangelo Chinello, et al.
Published: (2015-03-01)

Esclerose sistêmica e níveis séricos elevados de organoclorado: uma associação possível?
by: Odirlei André Monticielo, et al.